Global E-cigarette Leader Smoore Faces Competition Challenges

Aug.08.2022
China's largest e-cigarette company, Smoore International, faces competition as other companies receive tobacco production licenses.

The world's largest electronic cigarette company, Smoore International (06969.HK), is facing a challenge.


Recently, it was announced by Smore International that three fully-owned subsidiaries have received the Tobacco Monopoly Administration's Production License for Tobacco Monopoly Enterprises.


In the past two years, as regulations for electronic cigarettes have been gradually issued, the industry is moving towards standardization. Data shows that by 2022, the global electronic cigarette market will exceed $108 billion, attracting many industry giants to enter the market.


On the same day that the above notice was released, BYD Electronic and Jingjia Stock also announced that their subsidiaries had obtained exclusive production licenses. This has intensified the competition faced by SMOORE International.


A journalist from China Yangtze Daily noticed that in 2021, Smoore International held a global market share of 22.8%, exceeding the sum of the second to fifth largest companies, and maintained its position as the world's largest manufacturer of electronic atomization devices.


However, after moving towards standardization, the "age of profiteering" for the electronic cigarette industry will become a thing of the past. In the first half of this year, Smoore International's net profit is expected to decline by 46.0% to 53.8% year-on-year.


The industry is rapidly developing and enterprises are increasingly entering cross-border markets.


As the "Electronic Cigarette Management Measures" and mandatory national standards for electronic cigarettes have been introduced this year, the electronic cigarette industry is facing significant changes and gradually moving towards standardization.


Recently, Smoore International announced that its subsidiary has obtained a license to produce tobacco products. The company expressed confidence in its future development and stated that its overall production and operations will continue as planned. The company also affirmed its commitment to comply with relevant national policies and operate within the confines of the law.


According to data, the global electronic cigarette market size is expected to exceed $108 billion by 2022, with overseas markets sustaining a growth rate of 35%. Currently, there are over 1,500 electronic cigarette manufacturers and brands in China, with over 70% of them focused on exporting products overseas. Last year, Chinese electronic cigarette exports reached ¥138.3 billion, a year-on-year increase of 180%; it is expected that the total export value of electronic cigarettes for the whole year will reach ¥186.7 billion, with a growth rate of 35%.


The electronic cigarette industry is rapidly developing, with many large domestic companies diversifying into it. Manufacturing giants like Luxshare Precision, as well as Jingjia Allocation, Jinlong Machinery & Electronics, Shunhao Allocation, Jincheng Medicine, Boteng Allocation, and Huabao Allocation, have successively obtained production qualifications for electronic cigarettes. According to incomplete statistics, more than 130 enterprises have received compliant certificates as of now.


One notable development in the electronics industry is BYD's entry into the electronic cigarette market. Since 2018, BYD Electronics has been laying the groundwork for its electronic cigarette products, having completed patent layouts for its complete range of vaporization products, investment in automated production lines, and the integration of research and development of new materials, precision moulds, product design and development, as well as intelligent manufacturing capabilities.


Abundant production capacity leads to an increase in market share.


Despite facing increasingly fierce competition, Smurfit Kappa, as the industry leader, currently holds a relatively stable position.


In 2021, SMIC held a global market share of 22.8%, surpassing the combined total of second through fifth place. Furthermore, the company has ample production capacity with a scale of 2.59 billion standard units per year in 2021. The completion of its Jiangmen phases one and two will raise its total production capacity to over five billion standard units per year.


However, with the adjustments to regulations in the e-cigarette industry, the era of "excessive profits" will become a thing of the past. As a result, Smoore International experienced a decline in revenue growth during the first half of this year.


According to its recently released performance forecast, the company is expected to generate revenue of approximately RMB 1.322 billion to RMB 1.554 billion in the first half of the year, representing a year-on-year decrease of about 46.0% to 54.1%. The net profit is estimated to be about RMB 1.375 billion to RMB 1.606 billion, representing a year-on-year decrease of about 46.0% to 53.8%.


Simo International has announced a projected 50% decrease in revenue and net profit, citing reduced income from the Chinese market and a shift in product mix leading to lower gross margins. The company also reported significant increases in research and development expenses, management fees, and sales costs as it seeks to bolster its growth prospects in new areas.


It is worth mentioning that in terms of overseas business, Smoore International's major client under the British and American Tobacco umbrella, Vuse brand, has had three products approved through the Pre-Market Tobacco Product Application (PMTA), validating the company's supply chain capabilities. Additionally, the company's contract-manufactured disposable product Vuse go has been launched in non-US markets in Q2, and there will be a rapid increase in production of disposable products in the second half of the year, leading to an expected acceleration of overseas revenue growth in the latter half of the year.


In addition, Sumore International has increased its investment in research and development, with more than 3,000 patent applications filed to date. In 2021, the company's research and development expenses amounted to 670 million yuan, representing a year-on-year increase of 59.7%.


This article contains excerpts or reprints from third-party sources, which are owned by the original media and authors. If there is any infringement, please contact us for deletion. Any organization or individual that needs to reprint must contact the author and must not reprint directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
Product | Geek Bar Expands Meloso Lineup With the Launch of Meloso Max 2
Product | Geek Bar Expands Meloso Lineup With the Launch of Meloso Max 2
Geek Bar has added Meloso Max 2 to its official product lineup, further expanding its disposable vape portfolio. As the latest generation of the Meloso series, the new device introduces upgrades in endurance, device interaction and industrial design while reinforcing Geek Bar’s strategy of offering differentiated disposable products across multiple usage scenarios.
Jun.26
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai
InterTabac 2026: First conference program highlights now available online
InterTabac 2026: First conference program highlights now available online
With three months to go before the international tobacco and nicotine industry gathers again in Dortmund, InterTabac, together with NUBIZ and InterSupply, is set to bring around 800 exhibitors from across the globe to eleven exhibition halls. The three events will showcase innovation, market trends and industry networking, while the first conference program highlights are now online, offering trade visitors keynotes, panel discussions and masterclasses to support business decision-making.
Events
Jun.22
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18